Single Cell RNA Sequencing Identifies Subsets of Hepatic Stellate Cells and Myofibroblasts in Liver Fibrosis
Open accessThe DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Activation of hepatic stellate cells (HSCs) and their trans-differentiation towards collagen-secreting myofibroblasts (MFB) promote liver fibrosis progression. During chronic liver disease, resting HSCs become activated by inflammatory and injury signals. However, HSCs/MFB not only produce collagen, but also secrete cytokines, participate in metabolism, and have biomechanical properties. We herein aimed to characterize the heterogeneity of these liver mesenchymal cells by single cell RNA sequencing. In vivo resting HSCs or activated MFB were isolated from C57BL6/J mice challenged by carbon tetrachloride (CCl4) intraperitoneally for 3 weeks to induce liver fibrosis and compared to in vitro cultivated MFB. While resting HSCs formed a homogenous population characterized by high platelet derived growth factor receptor β (PDGFRβ) expression, in vivo and in vitro activated MFB split into heterogeneous populations, characterized by α-smooth muscle actin (α-SMA), collagens, or immunological markers. S100 calcium binding protein A6 (S100A6) was a universal marker of activated MFB on both the gene and protein expression level. Compared to the heterogeneity of in vivo MFB, MFB in vitro sequentially and only transiently expressed marker genes, such as chemokines, during culture activation. Taken together, our data demonstrate the heterogeneity of HSCs and MFB, indicating the existence of functionally relevant subsets in hepatic fibrosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“ScRNA-seq allows for high-resolution transcriptomic profiling of mesenchymal subpopulations during liver fibrosis, revealing that chemokine/cytokine release and extracellular matrix production are diversified among HSC/myofibroblast subpopulations owing to a higher degree of cellular heterogeneity than previously appreciated.109–111”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [110]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Fcna (a marker of quiescent hepatic stellate cells 53 )”
From Amphiregulin from regulatory T cells promotes liver fibrosis and insulin resistance in non-alcoholic steatohepatitis (2024) · cites this paper as [53]
In the citing paper
“scRNAseq data from mouse fibrosis models revealed that chemokine/cytokine release and ECM production appears to be diversified between HSC/myofibroblast subpopulations.130”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [130]
In the citing paper
“Unbiased cross-species mapping of scRNAseq data using canonical correlation analysis (CCA)21 confirmed that murine and human scar-associated macrophages represent corollary populations.”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Integrating single-cell transcriptomic data across different conditions, technologies, and species
Butler, A., Hoffman, P., Smibert, P., Papalexi, E., & Satija, R. (2018) · Nature Biotechnology · doi:10.1038/nbt.4096 · Cited by 13,174
Mechanisms of hepatic stellate cell activation
Tsuchida, T., & Friedman, S. L. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.38 · Cited by 2,909 · cited 1×
“Upregulated expression of chemokines, such as CCL2, CXCL1, or CXCL12, and collagens, particularly COL1A2, COL3A1, or COL5A2, are often named attributes for activated MFB [13].”
Dulai, P. S., Singh, S., Patel, J., Soni, M., Prokop, L. J., Younossi, Z., Sebastiani, G., Ekstedt, M., Hagstrom, H., Nasr, P., et al. (2017) · Hepatology · doi:10.1002/hep.29085 · Cited by 1,965 · cited 1×
“Liver fibrosis is also considered as a cornerstone event in the progression toward liver cirrhosis or hepatocellular carcinoma [15].”
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
Single cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations
MacParland, S. A., Liu, J. C., Ma, X.-Z., Innes, B. T., Bartczak, A. M., Gage, B. K., Manuel, J., Khuu, N., Echeverri, J., Linares, I., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06318-7 · Cited by 1,552
Hepatic stellate cells as key target in liver fibrosis
Higashi, T., Friedman, S. L., & Hoshida, Y. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.007 · Cited by 1,485 · cited 1×
“Preventing or reversing excessive hepatic scarring is a major therapeutic target in treating chronic liver diseases, such as viral hepatitis and alcoholic and non-alcoholic steatohepatitis [2].”
Pathobiology of liver fibrosis: a translational success story
Lee, Y. A., Wallace, M. C., & Friedman, S. L. (2015) · Gut · doi:10.1136/gutjnl-2014-306842 · Cited by 894 · cited 1×
“The upregulation of collagens and α-SMA in MFB is a well-established finding [16] and was confirmed by our single-cell based data for MFB in vivo as well as in vitro.”
Organ and tissue fibrosis: Molecular signals, cellular mechanisms and translational implications
Weiskirchen, R., Weiskirchen, S., & Tacke, F. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.06.003 · Cited by 538 · cited 1×
“At present, α-SMA is largely accepted as a marker of activated MFB [12].”
Self-citationInflammatory macrophages can transdifferentiate into myofibroblasts during renal fibrosis
Meng, X.-M., Wang, S., Huang, X.-R., Yang, C., Xiao, J., Zhang, Y., To, K.-F., Nikolic-Paterson, D. J., & Lan, H.-Y. (2016) · Cell Death & Disease · doi:10.1038/cddis.2016.402 · Cited by 325 · cited 2×
“Due to the combination of characteristics of myeloid leukocytes, as well as of myofibroblasts, cluster MFB II most likely includes trans-differentiated myeloid myofibroblasts, which have been described before [11].”
Weiskirchen, R., & Tacke, F. (2014) · PubMed · doi:10.3978/j.issn.2304-3881.2014.11.03 · Cited by 256 · cited 3×
“, contraction and vascular resistance regulation in the liver), and lipid metabolism to immune regulation [4], raising the question about yet unrecognized, functionally diverse subsets of HSCs/MFB.”
Self-citation
Cited by
Items 101–200 of 253
Nash, M. J., Dobrinskikh, E., Newsom, S. A., Messaoudi, I., Janssen, R. C., Aagaard, K. M., McCurdy, C. E., GANNON, M. A., Kievit, P., Friedman, J. E., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.154093 · Cited by 27
“This suggests that a subset of profibrogenic HSCs is sensitive to diet (52, 53), rather than a single homogenous cluster of activated HSCs, as described previously in mouse models of NASH (54–56).”
Wang, L., Huang, Y., Chen, J., Gao, J., Chen, S., Zhao, M., Lin, J., Zhou, S., Shen, Y., & Cheng, Y. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1635763 · Cited by 26
The Power of Single‐Cell Analysis for the Study of Liver Pathobiology
Chu, A., Schilling, J. D., King, K. R., & Feldstein, A. E. (2020) · Hepatology · doi:10.1002/hep.31485 · Cited by 26
Xiong, H., & Guo, J. (2025) · Pharmaceuticals · doi:10.3390/ph18040507 · Cited by 24
“In contrast, in mouse livers with carbon tetrachloride-induced fibrosis, PDGFR-positive myofibroblasts can be divided into four distinct subpopulations, distinguished by the most significantly expressed marker genes [105].”
Multiple Facets of Cellular Homeostasis and Regeneration of the Mammalian Liver
Huppert, S. S., & Schwartz, R. E. (2022) · Annual Review of Physiology · doi:10.1146/annurev-physiol-032822-094134 · Cited by 24
Animal and Human Models of Tissue Repair and Fibrosis: An Introduction
Lagares, D., & Hinz, B. (2021) · Methods in molecular biology · doi:10.1007/978-1-0716-1382-5_20 · Cited by 24
Kou, K., Sun, X., Tian, G., Yao, Z., Fan, Z., & Lv, G. (2022) · Journal of Immunology Research · doi:10.1155/2022/5091275 · Cited by 23
“It also shows that alpha-smooth muscle actin, a key marker of HSC activation, is only present in a subset of activated myofibroblasts, and S100A6 is a novel universal marker of activatedmyofibroblasts in liver fibrosis [183].”
The Pathophysiology of Portal Hypertension
Ramkissoon, R. A., Cao, S., & Shah, V. H. (2024) · Clinics in Liver Disease · doi:10.1016/j.cld.2024.03.001 · Cited by 23
Decoding liver fibrogenesis with single-cell technologies
Zhou, T., Musunuru, K., Lui, K. O., & Ding, Q. (2022) · Life Medicine · doi:10.1093/lifemedi/lnac040 · Cited by 22
“The Good, the Bad, and the Ugly” – About Diverse Phenotypes of Hepatic Stellate Cells in the Liver
Bogomolova, A., Balakrishnan, A., Ott, M., & Sharma, A. D. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.002 · Cited by 22
Cell atlas of CCl4-induced progressive liver fibrosis reveals stage-specific responses
Guo, P.-C., 吉林大学动物医学学院人兽共患病研究所人兽共患病研究教育部重点实验室, 人., Zuo, J., Huang, K.-K., Lai, G., Zhang, X., An, J., Li, J., Li, L., Wu, L. L., et al. (2023) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2023.031 · Cited by 21
Buchl, S. C., Hanquier, Z., Haak, A. J., Thomason, Y. M., Huebert, R. C., Shah, V. H., & Maiers, J. L. (2021) · Hepatology Communications · doi:10.1002/hep4.1835 · Cited by 20
“HSC subpopulations could be differentially impacted by longterm TNIK inhibition in our model as we observed decreased procollagen I and fibronectin expression while αSMA was unchanged.(32) Together, our data revealed a crucial fibrogenic role for TNIK in HSCs.”
BackgroundShen, S., Luo, J., & Ye, J. (2020) · Acta Tropica · doi:10.1016/j.actatropica.2020.105781 · Cited by 20
Phalloidin Staining for F-Actin in Hepatic Stellate Cells
Schröder, S. K., Tag, C. G., Weiskirchen, S., & Weiskirchen, R. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3207-9_4 · Cited by 20
Self-citationBouguéon, M., Legagneux, V., Hazard, O., Bomo, J., Siegel, A., Ferêt, J., & Théret, N. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1011858 · Cited by 19
“[17–19].”
BackgroundKimura, Y., Koyama, Y., Taura, K., Kudoh, A., Echizen, K., Nakamura, D., Li, X., Nam, N. H., Uemoto, Y., Nishio, T., et al. (2022) · Hepatology · doi:10.1002/hep.32586 · Cited by 19
Organelle stress and alterations in interorganelle crosstalk during liver fibrosis
Sinha, S., Hassan, N. A., & Schwartz, R. E. (2023) · Hepatology · doi:10.1097/hep.0000000000000012 · Cited by 19
“…sequencing studies of liver fibrogenesis in rodent models have greatly advanced our understanding of the heterogeneity of HSC phenotypes under normal and fibrotic states, [7 – 9] and their spatial and functional zonation across the hepatic lobule during centrilobular injury-induced fibrogenesis.”
BackgroundHepatic Stellate Cells Functional Heterogeneity in Liver Cancer
Sererols-Viñas, L., Garcia‐Vicién, G., Ruiz-Blázquez, P., Lee, T., Lee, Y. A., Gonzalez‐Sanchez, E., Vaquero, J., Moles, A., Filliol, A. A., & Affò, S. (2025) · Seminars in Liver Disease · doi:10.1055/a-2551-0724 · Cited by 18
A comprehensive molecular atlas of the mesenchymal cell types in the mouse liver
Pietilä, R. S., Genové, G., Mocci, G., Miao, Y., Liu, J., Leptidis, S., Gaudio, F. D., Uhrbom, M., Vázquez-Liébanas, E., Gustafsson, S., et al. (2025) · EMBO Reports · doi:10.1038/s44319-025-00580-9 · Cited by 18
“HSC have previously been characterized by scRNA-seq, and speci fi c marker genes have been proposed for their identi fi cation (Dobie et al, 2019b; Filliol et al, 2022; Krenkel et al, 2019; Mederacke et al, 2022b; Yang et al, 2021).”
Single-Cell Transcriptomics of Liver Cancer: Hype or Insights?
Zhang, Q., Ho, D. W., Tsui, Y., & Ng, I. O. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.04.014 · Cited by 18
Markovic, J., Li, R., Khanal, R., Peng, Q., Möbus, S., Yuan, Q., Engel, B., Taubert, R., Vondran, F. W. R., Bantel, H., et al. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.08.014 · Cited by 17
Aging disrupts hepatocyte zonation homeostasis in mice and humans
Sinha, S., Ali, Q., Zhang, T., T-Nguyen, D. H., Hanna, S., Sethiadi, J., Hissong, E. M., & Schwartz, R. E. (2025) · Hepatology · doi:10.1097/hep.0000000000001451 · Cited by 17
Cierpka, R., Weiskirchen, R., & Asimakopoulos, A. (2021) · Cells · doi:10.3390/cells10092184 · Cited by 17
“On day nine after seeding, when activation and trans-differentiation of the HSC was fully achieved [26,27], the cells and supernatants were harvested for protein expression analyses and Oil Red O staining.”
MethodSelf-citationLee, J., Kim, C. M., Cha, J. H., Park, J. Y., Yu, Y. S., Wang, H. J., Sung, P. S., Jung, E. S., & Bae, S. H. (2022) · Cells · doi:10.3390/cells11213387 · Cited by 16
Single‐cell RNA sequencing in oral science: Current awareness and perspectives
Wu, J., Ding, Y., Wang, J., Lyu, F., Tang, Q., Song, J., Luo, Z., Wan, Q., Lan, X., Xu, Z., et al. (2022) · Cell Proliferation · doi:10.1111/cpr.13287 · Cited by 16
“S100 calcium binding protein A6 (S100A6) was considered as a general marker of activated MFB.(98) It is promising that the MFB features identified in liver fibrosis supported by scRNA-seq have implications for deciphering MFBs during the fibrosis of OSMF.”
BackgroundWang, H., Zheng, S., Jiang, H., Wang, X., Zhou, F., & Weng, Z. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03263-4 · Cited by 16
A crosstalk between epigenetic modulations and non-alcoholic fatty liver disease progression
Ramezani, M., Zobeiry, M., Abdolahi, S., Hatami, B., Zali, M. R., & Baghaei, K. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154809 · Cited by 16
Chen, L., Huang, Y., Zhang, N., Qu, J., Fang, Y., Fu, J., Yuan, Y., Zhang, Q., Li, H., Wen, Z., et al. (2024) · MedComm · doi:10.1002/mco2.654 · Cited by 15
“27,28 29–31 However, the role of HSC inactivation, from aHSCs to inactivated HSCs (iHSCs), has not been explored to the same extent at the scRNA-seq level, with a major challenge being the evaluation of HSC inactivation status.”
BackgroundKang, K., Wang, X., Meng, C., Li, H., Sang, X., Zheng, Y., & Xu, H. (2019) · Annals of Translational Medicine · doi:10.21037/atm.2019.11.116 · Cited by 15
Balog, S., Fujiwara, R., Pan, S. Q., Elbaradie, K., Choi, H. Y., Sinha, S., Yang, Q., Asahina, K., Chen, Y., Li, M., et al. (2022) · Hepatology · doi:10.1002/hep.32793 · Cited by 15
Karri, K., & Waxman, D. J. (2023) · RNA · doi:10.1261/rna.079580.123 · Cited by 15
Kimer, N., Grønbæk, H., Fred, R. G., Hansen, T. F., Deshmukh, A. S., Mann, M., & Bendtsen, F. (2020) · BMJ Open · doi:10.1136/bmjopen-2019-035284 · Cited by 15
Dai, W., Guo, Y., Shen, Z., Wang, J., Lu, L., Dong, H., & Cai, X. (2023) · Human Cell · doi:10.1007/s13577-023-00889-4 · Cited by 14
“In contrast, S100A6 was known to be capable of boosting the activation of HSCs and may serve as a marker for collagen-secreting myofibroblasts [15, 19].”
BackgroundPlaying Jekyll and Hyde—The Dual Role of Lipids in Fatty Liver Disease
Molenaar, M. R., Penning, L. C., & Helms, J. B. (2020) · Cells · doi:10.3390/cells9102244 · Cited by 14
Application of single-cell RNA sequencing technology in liver diseases: a narrative review
He, L., Lu, A., Qin, L., Zhang, Q., Ling, H., Tan, D., & He, Y. (2021) · Annals of Translational Medicine · doi:10.21037/atm-21-4824 · Cited by 14
Meta-Analysis of Human and Mouse Biliary Epithelial Cell Gene Profiles
Verhulst, S., Roskams, T., Sancho‐Bru, P., & van Grunsven, L. A. (2019) · Cells · doi:10.3390/cells8101117 · Cited by 14
“For instance, S100A6 was recently identified as a universal marker of activated myofibroblasts [61].”
BackgroundUnravelling fibrosis using single-cell transcriptomics
Dobie, R., & Henderson, N. C. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.09.004 · Cited by 14
“ScRNA-seq studies in a rodent model of liver fibrosis have shown that myofibroblasts are a heterogeneous population in the fibrotic liver [28].”
BackgroundMessner, C. J., Babrak, L. M., Titolo, G., Caj, M., Miho, E., & Suter‐Dick, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094372 · Cited by 13
“This has been recently demonstrated by the successful evaluation of the heterogeneity of resting hepatic stellate cells and activated myofibroblasts [15].”
MethodZhang, M., Jing, Y., Xu, W., Shi, X., Zhang, W., Chen, P., Cao, X., Han, X., Duan, X., & Ren, J. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06324-8 · Cited by 13
Sotoudeheian, M. (2024) · Current Protein and Peptide Science · doi:10.2174/0113892037315931240618085529 · Cited by 13
Zhan, T., Wu, Y., Deng, X., Li, Q., Chen, Y., Lv, J., Wang, J., Li, S., Wu, Z., Liu, D., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1286977 · Cited by 12
Unraveling the Complexity of Liver Disease One Cell at a Time
Bader, G. D., McGilvray, I. D., MacParland, S. A., Atif, J., & Thoeni, C. E. (2022) · Seminars in Liver Disease · doi:10.1055/s-0042-1755272 · Cited by 12
Curc-mPEG454, a PEGylated curcumin derivative, as a multi-target anti-fibrotic prodrug
Xiao, S., Deng, Y., Shen, N., Sun, Y., Tang, H., Hu, P., Ren, H., & Peng, M. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.108166 · Cited by 12
Special Issue on “Cellular and Molecular Mechanisms Underlying the Pathogenesis of Hepatic Fibrosis”
Weiskirchen, R. (2020) · Cells · doi:10.3390/cells9051105 · Cited by 12
“now characterized the heterogeneity of these liver mesenchymal cells by single cell RNA sequencing [47].”
Self-citationPeriductal fibroblasts participate in liver homeostasis, fibrosis, and tumorigenesis
Wang, S.-S., Yuan, J., Tang, X. T., Yin, X., Fang, K., Chen, L. V., Ren, Z., & Zhou, B. O. (2025) · The Journal of Experimental Medicine · doi:10.1084/jem.20232123 · Cited by 11
Single-cell transcriptomics reveals the impact of sex and age in the healthy human liver
Rahman, R. U., Epstein, E. T., Murphy, S. M., Amir-Zilberstein, L., Aubin, C., Delorey, T. M., Koene, H., Fernandes, L., Tanabe, K. K., Qadan, M., et al. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101773 · Cited by 11
Choi, Y., Kim, M. S., Rhoades, J. H., Johnson, N. M., Berry, C. T., Root, S., Chen, Q., Tian, Y., Fernandez, R. J., Cramer, Z., et al. (2023) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2023.06.003 · Cited by 11
“associated with stellate cell activation and inflammation, including TPM1, SLPI, C3, and CD74.(31,32) Interestingly, both HSC II and HSC III expressed CCNE1 (Figure 7G), a proliferating cell marker induced in stellate cells by cMycoverexpressing HEPs in an Alb-Myc mouse model of fibrosis.”
BackgroundBenítez, R., Caro, M., Andrés‐León, E., O’Valle, F., & Delgado, M. (2021) · British Journal of Pharmacology · doi:10.1111/bph.15752 · Cited by 11
Liu, Q., Song, Y., Cui, Y., Hu, C., Luo, Y., Hu, D., Wang, H., Li, K., Chen, J., & Xiao, H. (2021) · SSRN Electronic Journal · doi:10.1016/j.biocel.2022.106343 · Cited by 11
Type I IFN receptor blockade alleviates liver fibrosis through macrophage-derived STAT3 signaling
Park, S.-J., Garcia Diaz, J., Comlekoglu, T., & Hahn, Y. S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1528382 · Cited by 10
Spatial genomics: Mapping the landscape of fibrosis
Velu, P. P., Abhari, R. E., & Henderson, N. C. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.adm6783 · Cited by 10
Yan, X., Han, Q., Wang, Y., Li, W., Zhang, N., Xu, F., Chen, W., You, H., & Yang, A. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101637 · Cited by 10
“…in key genes associated with these processes, as well as HSC markers (referencing the gene set described by Filliol et al, 25 Dobie et al, 26 Krenkel et al 27 ), inflammation, ECM remodeling, and angiogenesis-related genes, in the livers of Loxl1 Δ Lrat mice compared with Loxl1 fl/fl…”
Dai, X., Zheng, H.-L., Ma, Y.-X., Wang, Y., Wang, M.-Q., Cai, H., Hu, Z., Wan, J., & Zhang, L. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2902062 · Cited by 10
“Previous single-cell studies have focused on the heterogeneity of these mesenchymal cells [4,16], especially HSCs, during disease or injury, and most current studies have focused on exploring the mechanism of qHSCs activation into aHSCs [17–19].”
BackgroundNing, M., Lu, D., Liang, D., & Ren, P. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1513993 · Cited by 10
Nanda, I., Schröder, S. K., Steinlein, C., Haaf, T., Buhl, E. M., Grimm, D. G., & Weiskirchen, R. (2022) · Cells · doi:10.3390/cells11182900 · Cited by 10
“In addition, HSC lines have a clonal origin and are biologically homogenous, allowing the performance of more reproducible experiments when compared to primary HSCs that constitute a highly heterogeneous cell population [2].”
BackgroundSelf-citationHaaker, M. W., Goossens, V., Hoogland, N. A. N., van Doorne, H., Wang, Z., Jansen, J. W. A., Kaloyanova, D. V., van de Lest, C. H. A., Houweling, M., Vaandrager, A. B., et al. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2024.159540 · Cited by 9
“Markers for these timepoints corresponded with different in vivo HSC populations acquired from mice treated for 3 weeks with CCL 4 [65], suggesting that in vivo early and prolonged activated HSCs can coexist during liver damage.”
BackgroundGenetic Characterization of Rat Hepatic Stellate Cell Line PAV-1
Gäberlein, K., Schröder, S. K., Nanda, I., Steinlein, C., Haaf, T., Buhl, E. M., Sauvant, P., Sapin, V., Abergel, A., & Weiskirchen, R. (2023) · Cells · doi:10.3390/cells12121603 · Cited by 9
Self-citationSingle cell multiomics reveals drivers of metabolic dysfunction-associated steatohepatitisPreprint
Elison, W. S., Chang, L., Xie, Y., Miciano, C., Yang, Q., Mummey, H. M., Lancione, R., Corban, S., Sakane, S., Lucero, J. D., et al. (2025) · medRxiv · doi:10.1101/2025.05.09.25327043 · Cited by 9
Ye, H., He, Q., Qi, F., Xu, G., Qahar, M., Deng, C., & Wei, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1609288 · Cited by 8
Subpopulations of fibroblasts derived from human iPS cells
Kobayashi, T., Yamashita, A., Tsumaki, N., & Watanabe, H. (2024) · Communications Biology · doi:10.1038/s42003-024-06419-8 · Cited by 8
Watakabe, K., Miyoshi, M., Kakinuma, S., Sato, A., Tsuchiya, J., Shimizu, T., Mochida, T., Inada, K., Kaneko, S., Kawai‐Kitahata, F., et al. (2024) · The FASEB Journal · doi:10.1096/fj.202400109r · Cited by 8
Sun, Z., & Chen, G. (2024) · Tissue and Cell · doi:10.1016/j.tice.2024.102559 · Cited by 8
Chen, N., Liu, S., Qin, D., Guan, D., Chen, Y., Hou, C., Zheng, S., Wang, L., Chen, X., Chen, W., et al. (2023) · Cell Proliferation · doi:10.1111/cpr.13500 · Cited by 8
Single‐Cell Transcriptomics Reveals the Ameliorative Effect of Oridonin on Septic Liver Injury
Liu, J., Zhang, Q., Wong, Y. K., Luo, P., Chen, J., Xie, L., Chen, J., He, X., Shi, F., Gong, P., et al. (2024) · Advanced Biology · doi:10.1002/adbi.202300542 · Cited by 8
Optimized Isolation and Characterization of C57BL/6 Mouse Hepatic Stellate Cells
Balaphas, A., Meyer, J., Gameiro, C., Frobert, A., Giraud, M., Egger, B., Bühler, L. H., & Gonelle‐Gispert, C. (2022) · Cells · doi:10.3390/cells11091379 · Cited by 8
Beyond hepatic stellate cell heterogeneity: Resolving fibrosis, restoring regeneration (Review)
Gao, C., Chen, G., Jia, H., Zhu, H., Cai, Y., Yang, D., & Zhao, K. (2026) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2026.5733 · Cited by 8
“Conventional paradigms have portrayed HSCs as a func‑ tionally homogeneous population uniformly transitioning into profibrotic myofibroblasts (18,19).”
Lee, S., Jang, Y., Seok, H., & Moon, Y. (2025) · The FASEB Journal · doi:10.1096/fj.202403146rr · Cited by 7
“The apparent contradiction in the role of p53 between these findings and our results may be due to the inherent heterogeneity of HSCs, as revealed by single-cell RNA sequencing studies [61–63].”
Li, X., Li, T., Liu, S., Zhao, Y., Chen, Y., Abudureyimu, A., Zhang, S., Ge, L., Yang, Q., Meng, Y., et al. (2025) · Pediatric Research · doi:10.1038/s41390-025-04100-2 · Cited by 6
Duc, P. M., Thủy, L. T. T., Hai, H., Bao, T. V., Ha, N. T., Anh, P. T., Ikenaga, H., Fujii, H., Yoshida, K., Enomoto, M., et al. (2026) · JHEP Reports · doi:10.1016/j.jhepr.2026.101783 · Cited by 6
Buitkamp, L. F., Liehr, T., Kankel, S., Buhl, E. M., Hardt, K., Keller, D. T., Schröder, S. K., & Weiskirchen, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167764 · Cited by 5
Self-citationLi, Z., Zhao, H., Wang, S., Yan, P., Yuan, H., Zhao, M., Wan, R., Wang, J., Zhu, Z., Li, Z., et al. (2023) · Fibrosis · doi:10.35534/fibrosis.2023.10004 · Cited by 5
Miao, Z., Ding, Y., Zhao, N., Chen, X., Cheng, H.-X., Wang, J., Liu, Y., & Wang, F. (2020) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2020.105696 · Cited by 5
Structure, Function and Responses to Injury
Crawford, J. M., Bioulac‐Sage, P., & Hytiroglou, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00001-6 · Cited by 5
Ipsen, D. H., Agerskov, R. H., Klæbel, J. H., Lykkesfeldt, J., & Tveden‐Nyborg, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-82643-0 · Cited by 5
Bouezzedine, F., Thomas, C., & Théret, N. (2025) · Hepatology Research · doi:10.1111/hepr.70032 · Cited by 4
Li, Y., Wu, W., Lv, H., Shi, L., Wang, Z., Zhu, C., Zhang, J., Shen, X., Qu, Y., Xu, W., et al. (2026) · Genome Medicine · doi:10.1186/s13073-026-01641-x · Cited by 4
“Recently, fibrotic cell heterogeneity and functional diversity have been revealed in tissue fibrosis processes such as renal fibrosis [11], liver fibrosis [12] and skin scar formation [13].”
TGFb signaling instructs a conserved fibrosis-associated cell state marked by LRRC15
Shyer, J. A., Wehbe, F., Davidson, C. D., Bender, H. S., Thai, M., Cox, C., Missarova, A., Arlantico, A., Hall, B. M., Zhang, R., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2536550123 · Cited by 4
RNA methylations in hepatic fibrosis, a gradually emerging new treatment strategy
Cheng, C., Wu, Y., Wang, X., Xue, Q., Huang, Y., Liao, F., Wang, X., Duan, Q., & Miao, C. (2023) · Cell & Bioscience · doi:10.1186/s13578-023-01066-8 · Cited by 4
“Further, a sustained increase in insoluble fibers and structural alteration events in the liver occurs, ultimately leading to continued exacerbation of HF and malignant transformation [38].”
BackgroundThe Rule‐Based Model Approach: A Kappa Model for Hepatic Stellate Cells Activation by TGFB1
Bouguéon, M., Boutillier, P., Ferêt, J., Hazard, O., & Théret, N. (2022) · Wiley eBooks · doi:10.1002/9781119716600.ch4 · Cited by 4
Jenkins, T. L., Venkataraman, S., Saleh, A. M., Calve, S., Pourdeyhimi, B., & Little, D. (2025) · Journal of Tissue Engineering and Regenerative Medicine · doi:10.1155/term/2184723 · Cited by 3
Duan, X.-L., Zhao, T., Wang, J., Wang, J., & Zheng, Y. (2023) · European Journal of Integrative Medicine · doi:10.1016/j.eujim.2023.102278 · Cited by 3
How single-cell transcriptomics provides insight on hepatic responses to TCDD
Nault, R. (2023) · Current Opinion in Toxicology · doi:10.1016/j.cotox.2023.100441 · Cited by 3
The interplay between biomechanics and cell kinetics explains the spatial pattern in liver fibrosisPreprint
Zhao, J., Hammad, S., de Langlard, M., Erdoesi, P., Li, Y., Liedekerke, P. V., Buttenschön, A., Winkler, M., Kürschner, S. W., Reiners-Koch, P.-S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.31.667562 · Cited by 3
Liao, J., Yuan, Q., Luo, L., Hu, X., Li, Z., & Zhang, Z. (2024) · Journal of Cell Communication and Signaling · doi:10.1002/ccs3.12033 · Cited by 2
“According to the markers of each cluster provided by Krenkel et al., 13 cluster 4, 6, 7, 8, 10, and 13 are the early stage of activated MFB, termed MFB I, and their markers include α‐ Sma ( Acta2 ), Tagln , Col1a1 , Tpm1 and Col6a3 (Figure 3B).”
BackgroundMethodRaman imaging investigation of hepatic LX-2 cell reversion under different lipidic treatments
Valentino, G., Widak, A., Scopacasa, B., Tirinato, L., Parrotta, E. I., Perozziello, G., Pujia, A., Cuda, G., Luciani, P., & Candeloro, P. (2025) · Journal of Materials Chemistry B · doi:10.1039/d4tb02082k · Cited by 2
Zou, Y., Wu, J., Cheng, S., Cheng, D., Chen, T., Guo, X., Tang, L., Su, X., Zhang, M., Zhang, X., et al. (2025) · Molecular Metabolism · doi:10.1016/j.molmet.2025.102164 · Cited by 2
Hu, W., Ni, J., Zheng, S., Wei, X., Zhai, D., Qi, J., Ye, X., Lu, M., Bian, H., Li, J., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.12.016 · Cited by 2
“S100 calcium-binding protein A6 (S100A6) was a universal marker of activated myofibroblasts 19 .”
Heckmann, M., Djerir, N. E. H., Greliche, K., Commère, P., Fernandes, J., Sarrabayrouse, G., Hainque, B., Bigey, P., Escriou, V., & Hoffmann, C. (2026) · The FASEB Journal · doi:10.1096/fj.202502655rr · Cited by 2
Established Hepatic Stellate Cell Lines in Hepatology Research
Weiskirchen, R. (2023) · Fibrosis · doi:10.35534/fibrosis.2023.10003 · Cited by 2
Self-citationZhao, G., Li, Y., Li, H., Bao, M., Lubamba, G. P., Wang, G., Han, B. R., Tang, Y., Li, T., & Li, C. (2025) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2025.03.027 · Cited by 2
“At the protein level, S100A6 is recognized as a universal marker of activated myofibroblasts, consistent with our observations in the COKC microenvironment [59].”
A20 Attenuates Lipopolysaccharide-Induced Inflammation Through MAPK/ERK/JNK Pathway in LX-2 Cells
Wang, X., Han, F., Shen, Y., Chen, Y., & Ji, Z. (2021) · Hepatitis Monthly · doi:10.5812/hepatmon.114050 · Cited by 2
Tudor staphylococcal nuclease (Tudor‐ SN ) regulates activation of quiescent hepatic stellate cells
Qian, B., Zhao, Y., Zhang, X., Zhao, C., Cui, X., Wang, F., Jing, X., Ge, L., Yao, Z., Gao, X., et al. (2025) · FEBS Journal · doi:10.1111/febs.70073 · Cited by 1
An overview and pathophysiology of liver diseases
Kaur, S., & Tripathi, D. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-323-99478-1.00001-8 · Cited by 1
Liu, S., Tan, P., Chen, J., Huang, Z., Ren, B., Jiang, Z., Gu, B., Yu, W., Sun, L., Chen, Y., et al. (2025) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2025.101559 · Cited by 1
(2025) · Pakistan Veterinary Journal · doi:10.29261/pakvetj/2025.161 · Cited by 1
Qi, Y. A., Sun, M., Xu, F., Zhou, H., Yuan, L., Yu, X., Cao, S., & Hua, R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1635137 · Cited by 1
Alexander, K., Peiyin, H., Yibu, C., Biswas, S., & Douglas, E. A. (2025) · Fibrosis · doi:10.70322/fibrosis.2025.10012 · Cited by 1
S100A6 Regulated by PATZ1 Promotes Liver Fibrosis by Activating Hepatic Stellate Cells
Xue, Q., Peng, F., Guo, C., Zhou, Y., Zhong, L., Huang, L., Li, S., Deng, L., & Zhao, J. (2025) · Digestive Diseases and Sciences · doi:10.1007/s10620-025-09533-7 · Cited by 1
Zhong, X., Lu, J., Yang, X., Chen, H., Wang, W., Jun, Z., Zhao, Q., & Zhu, L. (2026) · Hepatology International · doi:10.1007/s12072-025-11024-w · Cited by 1
“…up less than 10% of healthy liver cells, and the process by which they become activated and differentiate into myofibroblasts due to hepatocyte injury and chronic inflammation is a hallmark of liver fibrosis, but the intricate complexity and heterogeneity of HSCs in each stage still exist [39–41].”
Attenuated crosstalk between urothelium and fibroblasts promotes ureteral stricture development
Guo, R., Zhang, X., Wang, C., Cui, J., Wang, K., Hua, B., Song, S., Zou, Y., Zhou, L., Tan, H., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1786116 · Cited by 1
Metadata
- Authors
- Krenkel, O., Hundertmark, J., Ritz, T., Weiskirchen, R., & Tacke, F.
- Affiliations
- Boehringer Ingelheim (Germany) (DE)
- Universitätsklinikum Aachen (DE)
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- Tacke, Frank
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2019-05-24
- Volume
- 8
- Issue
- 5
- Pages
- 503
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC6562512
- OpenAlex
- W2945705065
- Cited by
- 241
- References
- 20
- Citations by year
- 2026: 19 · 2025: 41 · 2024: 23 · 2023: 40 · 2022: 38 · 2021: 37 · 2020: 33 · 2019: 10
- FWCI
- 18.80
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Deutsche Forschungsgemeinschaft (SFB/TRR57, Ta434/3-1, Ta434/5-1)
- Topics
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
- Keywords
- hepatic stellate cells, myofibroblasts, liver fibrosis, cellular heterogeneity, hepatic stellate cell activation, transdifferentiation, S100A6, PDGFRβ, alpha-smooth muscle actin, collagen, carbon tetrachloride, chemokines, single-cell RNA sequencing
- MeSH terms
- S100 Calcium Binding Protein A6, Actins, Animals, Base Sequence, Carbon Tetrachloride, Cells, Cultured, Collagen, Disease Models, Animal, Liver, Liver Cirrhosis, Mice, Inbred C57BL, Gene Expression, Sequence Analysis, RNA, Genetic Heterogeneity, Cell Cycle Proteins, Chemokines, Receptor, Platelet-Derived Growth Factor beta, Mice, Hepatic Stellate Cells, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.